|
|
Name: |
VR Adviser LLC |
City: |
New York |
State: |
NY |
Zip: |
10018 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
14 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
RYZB |
Rayzebio, Inc. |
1 |
- |
$62.49 |
$250,574,000 |
4,030,471 |
17.19% |
161,400,000 |
13,624 |
6.63 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
3 |
- |
$0.00 |
$95,247,000 |
3,395,606 |
6.53% |
62,616,000 |
1,832,093 |
10.249 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
4 |
- |
$14.67 |
$84,564,000 |
3,882,623 |
5.8% |
37,277,000 |
800,001 |
8.565 |
N/A |
|
FDMT |
4d Molecular Therapeutics Inc. |
5 |
- |
$0.00 |
$69,371,000 |
3,424,031 |
4.76% |
31,181,000 |
424,031 |
10.571 |
N/A |
|
MRUS |
Merus Nv |
6 |
- |
$44.77 |
$59,076,000 |
2,148,214 |
4.05% |
18,372,000 |
422,000 |
5.034 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
7 |
- |
$0.00 |
$58,202,000 |
2,563,952 |
3.99% |
28,169,000 |
590,699 |
9.911 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
8 |
- |
$0.60 |
$51,061,000 |
2,372,714 |
3.5% |
47,447,000 |
2,077,680 |
3.879 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
9 |
- |
$12.49 |
$50,136,000 |
4,092,731 |
3.44% |
22,048,000 |
1,176,064 |
12.123 |
N/A |
|
HLVX |
Hillevax, Inc. |
12 |
- |
$13.13 |
$33,304,000 |
2,075,000 |
2.28% |
5,902,000 |
37,687 |
6.207 |
N/A |
|
TERN |
Terns Pharmaceuticals, Inc. |
14 |
- |
$5.99 |
$29,186,000 |
4,497,117 |
2% |
13,632,000 |
1,404,844 |
8.061 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
22 |
- |
$0.00 |
$22,341,000 |
2,428,385 |
1.53% |
9,377,000 |
285,529 |
6.176 |
N/A |
|
APLT |
Applied Therapeutics Inc. |
23 |
- |
$0.00 |
$20,938,000 |
6,250,000 |
1.44% |
6,849,000 |
591,966 |
13.018 |
N/A |
|
LYRA |
Lyra Therapeutics, Inc. |
26 |
- |
$0.00 |
$13,496,000 |
2,575,593 |
0.93% |
9,882,000 |
1,651,423 |
4.9 |
N/A |
|
SLRN |
Acelyrin, Inc. |
30 |
- |
$4.73 |
$6,991,000 |
937,113 |
0.48% |
-1,799,000 |
72,781 |
0.964 |
N/A |
|